Kobo Biotech Limited (BOM:531541)
India
· Delayed Price · Currency is INR 2.720
+0.010 (0.37%)
At close: May 19, 2025
Kobo Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | -49.29 | -55.53 | -152.26 | -192.31 | -210.06 | Upgrade
|
| Depreciation & Amortization | 40.71 | 40.72 | 46.06 | 56.37 | 58.78 | Upgrade
|
| Other Operating Activities | - | - | 1.34 | 108.41 | 144.75 | Upgrade
|
| Change in Accounts Receivable | -0.13 | -1.56 | 806.75 | 8.14 | -26.8 | Upgrade
|
| Change in Inventory | - | - | 352.38 | - | - | Upgrade
|
| Change in Accounts Payable | 10.45 | 25.63 | -82.79 | 33.72 | - | Upgrade
|
| Change in Other Net Operating Assets | 0.29 | -0.51 | -33.92 | 10.77 | 178.09 | Upgrade
|
| Operating Cash Flow | 2.04 | 8.75 | 937.57 | 25.09 | 144.76 | Upgrade
|
| Operating Cash Flow Growth | -76.72% | -99.07% | 3636.53% | -82.67% | -30.89% | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.03 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 128.92 | - | - | Upgrade
|
| Investment in Securities | - | - | 121.93 | - | - | Upgrade
|
| Other Investing Activities | - | - | 0.05 | - | - | Upgrade
|
| Investing Cash Flow | - | - | 250.9 | - | -0.03 | Upgrade
|
| Short-Term Debt Issued | 7.96 | - | - | 111.62 | - | Upgrade
|
| Total Debt Issued | 7.96 | - | - | 111.62 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -1,198 | - | - | Upgrade
|
| Long-Term Debt Repaid | -9.46 | -8.74 | -3.31 | -13.99 | - | Upgrade
|
| Total Debt Repaid | -9.46 | -8.74 | -1,201 | -13.99 | - | Upgrade
|
| Net Debt Issued (Repaid) | -1.5 | -8.74 | -1,201 | 97.63 | - | Upgrade
|
| Other Financing Activities | - | - | -1.34 | -108.41 | -144.75 | Upgrade
|
| Financing Cash Flow | -1.5 | -8.74 | -1,203 | -10.77 | -144.75 | Upgrade
|
| Net Cash Flow | 0.54 | 0.01 | -14.34 | 14.32 | -0.02 | Upgrade
|
| Free Cash Flow | 2.04 | 8.75 | 937.57 | 25.09 | 144.73 | Upgrade
|
| Free Cash Flow Growth | -76.72% | -99.07% | 3636.53% | -82.66% | -30.90% | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.37 | 39.35 | 1.05 | 6.08 | Upgrade
|
| Cash Interest Paid | - | - | 1.34 | 108.41 | 144 | Upgrade
|
| Levered Free Cash Flow | 20.42 | 32.92 | 975.9 | -7.52 | -76.99 | Upgrade
|
| Unlevered Free Cash Flow | 20.42 | 32.92 | 976.74 | 59.98 | 13.01 | Upgrade
|
| Change in Net Working Capital | -10.61 | -23.56 | -1,042 | -52.63 | -7.29 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.